Infectious diseases continue to take a toll on human health, affecting all aspects of our lives. Fast development of preventative vaccines and therapeutic treatments has become imperative as the increased globalization of our modern world enables the rapid spread of infectious diseases.
Persistent use of antibiotics has provoked the emergence of multidrug resistant bacteria, creating therapeutic challenges that need to be adressed by the development of novel therapeutics or combination therapies.
We offer a diverse product portfolio that helps scientists make critical discoveries through genomic analysis, in vitro, cell-based, and in vivo studies, accelerating their ability to develop treatments and vaccines.